Evaxion Biotech A/S
NASDAQ:EVAX

Watchlist Manager
Evaxion Biotech A/S Logo
Evaxion Biotech A/S
NASDAQ:EVAX
Watchlist
Price: 3.04 USD 6.67% Market Closed
Market Cap: 3.6m USD

Intrinsic Value

The intrinsic value of one EVAX stock under the Base Case scenario is 77.36 USD. Compared to the current market price of 3.04 USD, Evaxion Biotech A/S is Undervalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EVAX Intrinsic Value
77.36 USD
Undervaluation 96%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare EVAX to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EVAX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Evaxion Biotech A/S
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Evaxion Biotech A/S

Current Assets 8.8m
Cash & Short-Term Investments 6m
Receivables 1.5m
Other Current Assets 1.3m
Non-Current Assets 3.7m
PP&E 3.5m
Other Non-Current Assets 206k
Efficiency

Free Cash Flow Analysis
Evaxion Biotech A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Evaxion Biotech A/S

Revenue
3.3m USD
Operating Expenses
-17.5m USD
Operating Income
-14.2m USD
Other Expenses
862k USD
Net Income
-13.3m USD
Fundamental Scores

EVAX Profitability Score
Profitability Due Diligence

Evaxion Biotech A/S's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

31/100
Profitability
Score

Evaxion Biotech A/S's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

EVAX Solvency Score
Solvency Due Diligence

Evaxion Biotech A/S's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
37/100
Solvency
Score

Evaxion Biotech A/S's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EVAX Price Targets Summary
Evaxion Biotech A/S

There are no price targets for EVAX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Evaxion Biotech A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for EVAX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y